Back to NGNE

UBS Group AG → NGNE

UBS Group AG NGNE Position History

Neurogene Inc. • Healthcare

Quarters held
13
Latest value
$11.6M
Q3 2026
Peak value
$11.6M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$75K
Q3 2025$3.9M
Q3 2025$1K
Q4 2025$89K
Q4 2025$3.1M
Q4 2025$639
Q1 2026$1K
Q1 2026$3.7M
Q1 2026$63K
Q2 2026$2K
Q2 2026$5.4M
Q3 2026$2K
Q3 2026$11.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$11.6M417.6K——
Q3 2026$2K88——
Q2 2026$5.4M171.2K——
Q2 2026$2K62——
Q1 2026$63K3.1K——
Q1 2026$3.7M182.5K——
Q1 2026$1K70——
Q4 2025$63931——
Q4 2025$3.1M149.8K——
Q4 2025$89K4.3K——
Q3 2025$1K79——
Q3 2025$3.9M223.3K——
Q3 2025$75K4.3K——

Other funds holding NGNE

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B